SLC30A3 and Alzheimer disease: The mechanism(s) underlying this change require further investigation to determine whether loss of ZnT3 expression exacerbates the disease, or occurs as a protective mechanism to reduce synaptic Zn2+ levels in the face of AD-related increases in brain Zn2+ levels.